Trump’s Gaza threat shows the Middle East is both safer and more turbulent post-war

| Insights & Views

United States President Donald Trumps suggestion that the U.S. will take over war-torn Gaza and create a Riviera of the Middle East has been immediately condemned by the international community, including American allies...

Hard bites and slow songs: How beak size affects the singing and evolution of songbirds

| Insights & Views

The Java sparrow is ready for the video recording. As I hold it carefully in my hand in order to transfer it to the recording cage, the little gray bird bites my finger with its thick red bill. Ouch! Though the bite isnt...

Turkey’s earthquake reconstruction efforts must balance speed with fairness

| Insights & Views

Two years after the devastating 2023 earthquakes in Turkey that killed about 60,000 people and caused the collapse of 57,000 buildings, the countrys recovery remains slow, fragmented, and heavily politicized. Despite...

Three pop beefs that were more cutting than Matty Healy and Taylor Swift’s

| Insights & Views

There has been a sharp intake of breath among Taylor Swift fans following reports that 1975 frontman and songwriter Matty Healy is soon to release a song addressing their public romance from 2023. The song in question, God...

Why there’s an ethnic pension gap in the UK – and how the government could close it

| Insights & Views

Theres an ethnic pension gap in the UK that leaves people from particular minority ethnic communities worse off in retirement than their white British counterparts. The gap can be measured in several ways for example, by...

Millions of animals die on roads – does this make driving morally wrong?

| Insights & Views

Imagine one morning, you are deciding whether to drive to work or catch the train. Eventually, you decide to drive. On your way to the office, a squirrel crosses the road leaving you no time to react, and you run it over....

First new non-opioid painkiller approved in the US for decades – here’s how it works

| Insights & Views

A new non-opioid painkiller, suzetrigine, has just been approved by the US drug regulator, the FDA. It is the first non-opioid painkiller the agency has approved in over two decades. Because of their addictive nature,...